Exploring allele specific methylation in drug dependence susceptibility

Area of Science:

• Neuroscience
• Genetics
• Epigenetics

Background:

• Drug dependence is a complex neuropsychiatric condition influenced by genetic, epigenetic, and environmental factors.
• Allele-specific methylation (ASM), a stable epigenetic mechanism, involves genetic variants affecting methylation levels at CpG sites.

Purpose of the Study:

• To investigate the contribution of single-nucleotide polymorphisms (SNPs) influencing cis ASM to drug dependence susceptibility.
• To identify genetic and epigenetic markers associated with drug dependence, including cocaine dependence.

Main Methods:

• A case-control association study was conducted using discovery and independent follow-up samples from Spain.
• 182 SNPs known to influence cis ASM in human brain regions were selected for evaluation.
• Statistical analyses, including Bonferroni correction, were applied to identify significant associations.

Main Results:

• Five nominal associations were found in the discovery sample, with rs6020251 replicated in the follow-up sample.
• Pooled analysis revealed significant associations for rs6020251 and rs11585570 with drug dependence, surpassing Bonferroni correction.
• Similar results were observed when analyzing cocaine-dependent patients separately.
• rs6020251 is linked to CTNNBL1 gene methylation and regulatory regions in the brain.
• rs11585570 is an eQTL for SCP2 and ECHDC2 genes, associated with their promoter methylation.

Conclusions:

• The study highlights CTNNBL1, SCP2, and ECHDC2 genes as potential contributors to drug dependence susceptibility.
• Combining genetic and epigenetic data provides insights into the biological mechanisms underlying drug dependence.
• The identified SNPs and associated genes offer potential targets for future research and therapeutic strategies.